Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Girindus To Manufacture API for Cellceutix | Contract Pharma

What are you searching for?

Sign in
Breaking News

Girindus To Manufacture API for Cellceutix

Cellceutix Corp. has signed an agreement with Girindus America, Inc. for the manufacture of Kevetrin API.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cellceutix Corp. has signed an agreement with Girindus America, Inc. for the manufacture of Kevetrin API. Kevetrin is being developed to treat certain cancers. The company recently reported encouraging results in animal models of drug resistant lung cancers. Terms of the agreement were not disclosed.

“This is a big step toward our short-term goal of filing for an investigational new drug exemption (IND) with the FDA,” said George Evans, chief executive officer of Cellceutix. “We will use the material manufactured by Girindus to do the last animal studies needed for the filing of an IND, as well as for Phase I human trials. We think Girindus will be an excellent partner for Cellceutix.”

Sign up today for Contracting & Outsourcing 2009!
http://contractpharma.com/2009conference

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters